Skip to ContentSkip to Navigation
Practical matters How to find us prof. dr. F.G.A. (Frank) Jansman


Evidence- and consensus-based guidelines for drug-drug interactions with anticancer drugs: A practical and universal tool for management

Exploring co-dispensed drug use in patients on sevelamer or polystyrene sulfonate to identify potential novel binding interactions: a cross sectional in silico study: Potential novel binding interactions with resins

Exposure-toxicity relationship of cabozantinib in patients with renal cell cancer and salivary gland cancer

High prevalence of peripheral neuropathy in multiple myeloma patients and the impact of vitamin D levels, a cross-sectional study

The performance of COBRA, a decision rule to predict the need for intensive care interventions in intentional drug overdose

Binding interactions with sevelamer and polystyrene sulfonate in vitro

Exposure-toxicity analysis of cabozantinib in patients with salivary gland cancer and renal cell cancer

Prevalence and follow-up of potentially inappropriate medication and potentially omitted medication in older patients with cancer - The PIM POM study

The impact of a 1-hour time interval between pazopanib and subsequent intake of gastric acid suppressants on pazopanib exposure

Clinical implications of food-drug interactions with small-molecule kinase inhibitors

Read more


Aandacht voor geneesmiddeleninteracties nog niet optimaal.